— Know what they know.
Not Investment Advice
Also trades as: DCAL.BO (BSE) · $vol 0M

DCAL.NS NSE

Dishman Carbogen Amcis Limited
1W: -10.6% 1M: -17.3% 3M: -23.5% YTD: -28.4% 1Y: -43.8% 3Y: -1.8% 5Y: -29.3%
₹151.21 ($1.57)
+0.86 (+0.57%)
 
NSE · Healthcare · Biotechnology · Tech Score Sell · Power 26 · ₹23.5B mcap · 55M float · 0.621% daily turnover

📊 Key Metrics

TTM
₹29B
Revenue
+8.1% YoY
₹974M
Net Income
+2907.7% YoY
₹1B
Free Cash Flow
+38.1% YoY
26.0%
Gross Margin
8.6%
Op. Margin
2.6%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE1.6%
ROA0.9%
ROIC2.4%

Valuation

P/E35.1
P/B0.4
EV/EBITDA6.8

Leverage

Debt/Equity0.46
Current Ratio1.23
Interest Cov.1.5x

Quality Scores

Piotroski F5/9
Altman Z0.60
Beneish M-1.47

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms